Upcoming Investor Conferences for Sana Biotechnology
Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering company dedicated to transforming patient care through engineered cells, has announced its plans to participate in several significant investor conferences in September. These events will showcase the company's vision and recent advancements in cell therapy, offering valuable insights to stakeholders and potential investors.
Details on Conference Presentations
During the month of September, Sana has scheduled presentations at four notable investor conferences:
Citi's Biopharma Back-to-School Conference
Sana will kick off its conference schedule at Citi's 2025 Biopharma Back-to-School Conference, where it will present at 3:15 p.m. ET on September 2, 2025. This conference is a key platform for biopharma companies to discuss their latest innovations and strategies.
Wells Fargo Healthcare Conference
The following week, at 8:00 a.m. ET on September 4, 2025, Sana will present at the Wells Fargo Healthcare Conference. This event is renowned for bringing together leading healthcare companies to discuss market trends and opportunities.
Morgan Stanley Healthcare Conference
Sana's next presentation will be at the Morgan Stanley 23rd Annual Global Healthcare Conference, scheduled for 11:30 a.m. ET on September 8, 2025. This conference is an excellent opportunity for companies to articulate their strategies and outlook in the ever-evolving healthcare landscape.
HC Wainwright Investment Conference
Lastly, Sana will present at the HC Wainwright 27th Annual Global Investment Conference on September 9, 2025, at 9:30 a.m. ET. This renowned event focuses on emerging growth companies across various sectors, providing a platform for them to highlight their innovations.
Accessing the Webcasts
For those interested in attending these events virtually, the webcasts of Sana's presentations can be found on the Investor Relations page of their official website. Recordings will be available for 30 days post-conference, ensuring that stakeholders can catch up on the valuable insights shared.
About Sana Biotechnology
Sana Biotechnology is at the forefront of developing engineered cells as therapies for various diseases. The company envisions a world where genetic repair, the replacement of damaged cells, and accessible treatment options reshape healthcare delivery. With a team of dedicated professionals, Sana aims to create life-altering treatments that have the potential to change how diseases are managed and cured.
Getting in Touch
For investor relations inquiries, Nicole Keith can be contacted via email at investor.relations@sana.com. For media inquiries, reach out at media@sana.com.
Frequently Asked Questions
What events is Sana Biotechnology participating in this September?
Sana will participate in Citi's Biopharma Conference, Wells Fargo Healthcare Conference, Morgan Stanley Healthcare Conference, and HC Wainwright Investment Conference.
How can I watch Sana's presentations?
Webcasts will be available on Sana's Investor Relations page, with replays accessible for 30 days after each event.
What is the focus of Sana Biotechnology?
Sana Biotechnology focuses on developing engineered cells for treating diseases by repairing genes and replacing damaged cells.
Who can I contact for investor-related questions?
Investor relations inquiries can be sent to Nicole Keith at investor.relations@sana.com.
When does Sana Biotechnology's conference schedule begin?
Sana's conference schedule begins on September 2, 2025, at Citi's Biopharma Back-to-School Conference.